Gaboreau, Y.; Milovančev, A.; Rolland, C.; Eychenne, C.; Alcaraz, J.-P.; Ihl, C.; Mazet, R.; Boucher, F.; Vermorel, C.; Ostojic, S.M.;
et al. Molecular Hydrogen for Outpatients with COVID-19 (Hydro-COVID): A Phase 3 Randomised, Triple-Blinded, Pragmatic, Placebo-Controlled, Multicentre Trial. J. Clin. Med. 2024, 13, 4308.
https://doi.org/10.3390/jcm13154308
AMA Style
Gaboreau Y, Milovančev A, Rolland C, Eychenne C, Alcaraz J-P, Ihl C, Mazet R, Boucher F, Vermorel C, Ostojic SM,
et al. Molecular Hydrogen for Outpatients with COVID-19 (Hydro-COVID): A Phase 3 Randomised, Triple-Blinded, Pragmatic, Placebo-Controlled, Multicentre Trial. Journal of Clinical Medicine. 2024; 13(15):4308.
https://doi.org/10.3390/jcm13154308
Chicago/Turabian Style
Gaboreau, Yoann, Aleksandra Milovančev, Carole Rolland, Claire Eychenne, Jean-Pierre Alcaraz, Cordelia Ihl, Roseline Mazet, François Boucher, Celine Vermorel, Sergej M. Ostojic,
and et al. 2024. "Molecular Hydrogen for Outpatients with COVID-19 (Hydro-COVID): A Phase 3 Randomised, Triple-Blinded, Pragmatic, Placebo-Controlled, Multicentre Trial" Journal of Clinical Medicine 13, no. 15: 4308.
https://doi.org/10.3390/jcm13154308
APA Style
Gaboreau, Y., Milovančev, A., Rolland, C., Eychenne, C., Alcaraz, J.-P., Ihl, C., Mazet, R., Boucher, F., Vermorel, C., Ostojic, S. M., Borel, J.-C., Cinquin, P., & Bosson, J.-L.
(2024). Molecular Hydrogen for Outpatients with COVID-19 (Hydro-COVID): A Phase 3 Randomised, Triple-Blinded, Pragmatic, Placebo-Controlled, Multicentre Trial. Journal of Clinical Medicine, 13(15), 4308.
https://doi.org/10.3390/jcm13154308